CoreLogic Inc. (CLGX) Financials Nov 14, 2014, 4:28
CoreLogic Inc. (CLGX) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for CoreLogic Inc.
Fiscal year is January-December. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - 1.28B 1.34B 1.57B 1.33B
Cost of Goods Sold (COGS) incl. D&A - 910.97M 957.5M 973.31M 797.25M
COGS excluding D&A - 816.09M 841.95M 839.59M 670.23M
Depreciation & Amortization Expense - 94.88M 115.55M 133.71M 127.02M
Depreciation - 57.48M 87.25M 77.3M 61.8M
Amortization of Intangibles - 37.4M 28.3M 56.41M 65.22M
Gross Income - 369.3M 381.05M 594.33M 533.38M
2010 2011 2012 2013 5-year trend
SG&A Expense - 255.62M 290.56M 372.07M 360.51M
Research & Development - 0 - - -
Other SG&A - 255.62M 290.56M 372.07M 360.51M
Other Operating Expense - 0 0 0 0
Unusual Expense - 16.3M 12M - -
EBIT after Unusual Expense - (16.3M) (12M) - -
Non Operating Income/Expense - 5.42M 60.01M (2.52M) 12.03M
Non-Operating Interest Income - 4.27M 4.83M 3.06M 4.7M
Equity in Affiliates (Pretax) - 0 - 0 0
Interest Expense - 34.49M 52.92M 55.52M 52.35M
Gross Interest Expense - 34.49M 52.92M 55.52M 52.35M
Interest Capitalized - 0 0 0 0
Pretax Income - 72.57M 90.4M 167.28M 137.26M
Income Tax - 30.32M 67.18M 80.4M 34.47M
Income Tax - Current Domestic - - - 47.51M 14.46M
Income Tax - Current Foreign - - - (3.36M) 2.01M
Income Tax - Deferred Domestic - - - 26.55M 18.33M
Income Tax - Deferred Foreign - - - 9.7M (327,000)
Income Tax Credits - - - 0 0
Equity in Affiliates - 41.64M 30.27M 35.98M 27.36M
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - 83.89M 53.5M 122.86M 130.15M
Minority Interest Expense - 37.67M 980,000 (645,000) (53,000)
Net Income - 46.22M 52.52M 123.51M 130.2M
Extraordinaries & Discontinued Operations - (102.52M) (127.12M) (11.22M) (22.47M)
Extra Items & Gain/Loss Sale Of Assets - (18.99M) 0 3.84M (7.01M)
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - (83.54M) (127.12M) (15.06M) (15.46M)
Net Income After Extraordinaries - (56.3M) (74.61M) 112.29M 107.73M
Preferred Dividends - 0 0 0 0
Net Income Available to Common - 46.22M 52.52M 123.51M 130.2M
EPS (Basic) - (0.34) (0.68) 1.05 1.21
Basic Shares Outstanding - 111.53M 109.12M 102.91M 95.09M
EPS (Diluted) - (0.33) (0.68) 1.04 1.18
Diluted Shares Outstanding - 112.36M 109.71M 104.05M 97.11M
EBITDA - 208.56M 206.03M 355.97M 299.9M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...
Continue Reading
What's Behind Eric Dalton's Continued Recognition? Now, if you told me a healthcare leader’s named 'Visionary of the Year' twice in a row, my first thought isn't 'stretch goals' but 'show me the goods.' And that’s precisely what Eric J. Dalton has done. The Vice President at Angels on Call Homecare isn't just tooting his own horn; he's building a damn symphony in the...
Continue Reading
Breaking Updates Trump UX Changes Here's the real scoop: software updates that break functionality are setting companies back more than those user experience (UX) tweaks that folks gripe about but usually muddle through. According to a recent LITSLINK study, even three figures that supposedly quantify UX losses turn out to be questionable at best. Real-world Disasters:...
Continue Reading
Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...
Continue Reading
AppGate: Forging a Path in Digital Security In a world where cyber threats seem to lurk around every digital corner, snagging the title of a leader in digital risk protection from the SPARK Matrix is no small feat. Let’s dive deep into AppGate’s rise to the top in QKS Group’s 2026 evaluation. What Sets AppGate Apart? AppGate's leadership status isn't some overnight...
Continue Reading
AI-Revolutionizing Customer Service: The New Partnership Out of the boardroom and into the trenches, McKinsey joins hands with Parloa, aiming to reshape how enterprises handle customer service through artificial intelligence. Forget all the corporate fluff you've heard before; these guys are dead set on closing the massive gap companies face in deploying AI agents...
Continue Reading
An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...
Continue Reading
A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...
Continue Reading
AI Takes Center Stage in Wealth Management You know, it's not every day we see two powerhouses like BetaNXT and Pave Finance buddying up to shake up the financial advisory world. This partnership's all about harnessing AI to give wealth management firms and financial advisors some serious firepower in portfolio planning. BetaNXT, already a big name with its slick...
Continue Reading
Home Testing: A Game Changer for GI Patients Imagine dragging yourself out of bed, managing gut issues, only to face a grueling trip to a lab. It's the last thing a patient with GI symptoms wants. Enter Getlabs and Genova Diagnostics with a welcome shift: a partnership that promises to bring the lab to your doorstep—literally. The Partnership Expansion Getlabs, the...
Continue Reading
Top 5 Most Recently Viewed Articles
Infortar's Share Buyback Strategy Infortar is actively engaging in a share buyback program on the Nasdaq Tallinn Stock Exchange. This initiative reflects a strategic approach towards securing and stabilizing their market presence. During a recent period, Infortar made notable acquisitions of its own shares, an activity that signals confidence in its long-term value....
Continue Reading
Cisco Sets New Milestone with 52-Week High Cisco Systems Inc (NASDAQ: CSCO) has achieved a remarkable milestone as its shares soared to a 52-week high of $60.23. This surge reflects the company's impressive growth trajectory and consistent performance over the past year. With a current market capitalization of $239.6 billion, analysts suggest that the stock may be...
Continue Reading
Understanding the Disclosure Process for Life Science REIT Plc The disclosure of relevant securities for companies listed on the stock exchange is crucial for maintaining transparency and regulatory compliance. One important example is the recent public opening position disclosure by Life Science REIT Plc, a notable name in the real estate investment trust sector. This...
Continue Reading
Opportunities in Oversold Energy Stocks In the energy sector, there is often potential for long-term gains hidden within oversold stocks. When a stock exhibits an oversold condition, it's usually an indicator that investor sentiment has driven the price down more than justified by the company's fundamentals. This presents a buy opportunity for savvy investors....
Continue Reading
Terranet's Technology Development Progress Report Recently, Terranet has shared updates with stakeholders regarding its advancements in technology during the second quarter. The company has begun the initial integration of its system into a vehicle, which will lead to an expanded testing phase that will be reported back to the market. The analyses confirm that the ongoing...
Continue Reading